• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4616374)   Today's Articles (3145)   Subscriber (49395)
For: Jansson KP, Yu ASL, Stubbs JR. Contribution of phosphate and FGF23 to CKD progression. Curr Opin Nephrol Hypertens 2022;31:306-311. [PMID: 35283435 PMCID: PMC9232955 DOI: 10.1097/mnh.0000000000000793] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Number Cited by Other Article(s)
1
Nakamura N, Arai Y, Kitawaki T, Jo T, Mizumoto C, Kanda J, Nishikori M, Yamashita K, Takaori-Kondo A. Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T-cell therapy. Br J Haematol 2023;200:e1-e3. [PMID: 36220156 PMCID: PMC10092564 DOI: 10.1111/bjh.18504] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2022] [Revised: 09/26/2022] [Accepted: 09/27/2022] [Indexed: 11/29/2022]
2
Imig JD. Osteopontin Regulates Phosphate Solubility to Prevent Mineral Aggregates in CKD. KIDNEY360 2022;3:1477-1479. [PMID: 36245661 PMCID: PMC9528367 DOI: 10.34067/kid.0004292022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/01/2022] [Accepted: 08/12/2022] [Indexed: 12/20/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA